SCHEMBL8615853

SCHEMBL8615853

Cc1ccccc1-c1cc(NC(=N)NC=O)c2ccc(OCC(C)C)cc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 3/20 0.37
NQO2 P16083 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PKM P14618 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
TP53 P04637 2/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 3/20 0.33
THRB P10828 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
F2 P00734 1/20 0.33
PLG P00747 1/20 0.33
PRSS1 P07477 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8615222 0.92 TACR3 (0.35) TACR3NQO2MEN1KMT2APKM
SCHEMBL8613388 0.90 SMN1; SMN2 (0.39) TACR3MEN1KMT2APKMCA12
SCHEMBL8613990 0.88 TACR3 (0.39) TACR3NQO2MEN1KMT2APKM
SCHEMBL8615573 0.88 TACR3 (0.37) TACR3NQO2MEN1KMT2APKM
SCHEMBL8616577 0.87 NQO2 (0.36) TACR3NQO2MEN1KMT2APKM
SCHEMBL8619346 0.87 TACR3 (0.46) TACR3NQO2PKMCA12CA1
SCHEMBL8618941 0.86 CA2 (0.38) TACR3NQO2MEN1KMT2ACA12
SCHEMBL8617680 0.85 TACR3 (0.35) TACR3NQO2MEN1KMT2APKM
SCHEMBL8618215 0.83 CA2 (0.37) TACR3NQO2MEN1KMT2ACA12
SCHEMBL8617128 0.83 ACP1 (0.35) TACR3MEN1KMT2APKMCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed